
Purecarve 3.125mg Tablet
Marketer
Xenon Pharmaceuticals
Salt Composition
Carvedilol (3.125mg)
Overview Purecarve 3.125mg Tablet
Cardiovasc 3.125mg tablets effectively manage hypertension, angina pectoris, and congestive heart failure. Its mechanism involves vasodilation, improving blood flow to the heart. This, in turn, reduces the risk of myocardial infarction and cerebrovascular accident. Administer Cardiovasc 3.125mg tablets with food, following your physician's prescribed dosage and regimen. Consistent use is crucial, even with symptom improvement or normalized blood pressure. Discontinuation requires medical consultation to prevent potential complications. Lifestyle modifications, including regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as directed), enhance treatment efficacy. While generally well-tolerated, potential adverse effects such as lightheadedness, cephalgia, dyspnea, and fatigue may occur. Report persistent or bothersome side effects to your doctor. Prior to commencing treatment, disclose any pre-existing cardiac or renal conditions, and pregnant or lactating individuals should seek medical advice before use.
Primary Ingredients of Purecarve 3.125mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Purecarve 3.125mg Tablet
Managing elevated blood pressure | Addressing angina pectoris | Treating congestive heart failure
Major Benefits of Purecarve 3.125mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the 3.125mg Purecarve tablet whole; avoid chewing, crushing, or fracturing it. Consume with food.
Common Side effects of Purecarve 3.125mg Tablet:
- Decreased blood pressure
- Headache
- Fatigue
- Dizziness
- Breathlessness
How to use Purecarve 3.125mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the 3.125mg Purecarve tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.
How Purecarve 3.125mg Tablet works:
Carvedilol 3.125mg tablets combine alpha and beta-blocking actions. This dual mechanism reduces heart rate and dilates blood vessels, thereby improving the heart's pumping efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Purecarve 3.125mg Tablets is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Purecarve 3.125mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingSAFE IF PRESCRIBED
Lactation and Purecarve 3.125mg tablets appear compatible. Available human data indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Taking a Purecarve 3.125mg tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these side effects.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Purecarve 3.125mg tablets without a dosage change. Nevertheless, disclosure of pre-existing kidney conditions to your physician is advised. Routine blood pressure monitoring is suggested to guide dosage modifications.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Purecarve 3.125mg tablets; dosage modification may be necessary. Medical advice is recommended. Purecarve 3.125mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Purecarve 3.125mg Tablet :
Should you forget to take a Purecarve 3.125mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Purecarve 3.125mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Carbazole-propanol derivative |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Alpha-beta blocker |
